Basic Information
| RNALocate ID: | RLID:11002486 |
| RNA Symbol: | hsa-miR-373-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-373-3p |
| RNA ID: | miRBase:MIMAT0000726 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11002483 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11002484 | Exosome | Primary ovarian tumor cells|Serum | 18589210 |
| RLID:11002485 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11002487 | Exosome | Serum | 24683445 |
| RLID:11002488 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID-D:11001204 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
| RLID-D:11003928 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-373-3p | Splenic marginal zone lymphoma | MNDR-E-MI-45351 |
| MNDR | hsa-miR-373-3p | Medulloblastoma | MNDR-E-MI-45352 |
| MNDR | hsa-miR-373-3p | Lymphoma non-hodgkin | MNDR-E-MI-45353 |
| MNDR | hsa-miR-373-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-45354 |
| MNDR | hsa-miR-373-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-45355 |
| MNDR | hsa-miR-373-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-45356 |
| MNDR | hsa-miR-373-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-45357 |
| MNDR | hsa-miR-373-3p | Her2-receptor positive breast cancer | MNDR-E-MI-45358 |
| MNDR | hsa-miR-373-3p | Prostate cancer | MNDR-E-MI-45359 |
| MNDR | hsa-miR-373-3p | Gastric cancer | MNDR-E-MI-45360 |
| MNDR | hsa-miR-373-3p | Leukemia | MNDR-E-MI-45361 |
| MNDR | hsa-miR-373-3p | Ataxia telangiectasia | MNDR-E-MI-45362 |
| MNDR | hsa-miR-373-3p | Lung cancer | MNDR-E-MI-45363 |
| MNDR | hsa-miR-373-3p | Parkinson disease | MNDR-E-MI-45364 |
| MNDR | hsa-miR-373-3p | Breast cancer | MNDR-E-MI-45365 |
| MNDR | hsa-miR-373-3p | Pituitary neoplasms | MNDR-E-MI-45366 |
| MNDR | hsa-miR-373-3p | Pancreatic cancer | MNDR-E-MI-45367 |
| MNDR | hsa-miR-373-3p | Hepatitis C | MNDR-E-MI-45368 |
| MNDR | hsa-miR-373-3p | Nephroblastoma | MNDR-E-MI-45369 |
| MNDR | hsa-miR-373-3p | Colon cancer | MNDR-E-MI-45370 |
| MNDR | hsa-miR-373-3p | Familial ovarian cancer | MNDR-E-MI-45371 |
| MNDR | hsa-miR-373-3p | Germ cell cancer | MNDR-E-MI-45372 |
| MNDR | hsa-miR-373-3p | Glioblastoma | MNDR-E-MI-45373 |
| MNDR | hsa-miR-373-3p | Astrocytoma | MNDR-E-MI-45374 |
| MNDR | hsa-miR-373-3p | Glioma | MNDR-E-MI-45375 |
| MNDR | hsa-miR-373-3p | Osteosarcoma | MNDR-E-MI-45376 |
| MNDR | hsa-miR-373-3p | Fibrosarcoma | MNDR-E-MI-45377 |
| MNDR | hsa-miR-373-3p | Infarction middle cerebral artery | MNDR-E-MI-45378 |
| MNDR | hsa-miR-373-3p | Meningioma | MNDR-E-MI-45379 |
| MNDR | hsa-miR-373-3p | Uterine cancer | MNDR-E-MI-45380 |
| MNDR | hsa-miR-373-3p | Pituitary adenoma | MNDR-E-MI-45381 |
| MNDR | hsa-miR-373-3p | Pancreatic adenocarcinoma | MNDR-E-MI-45382 |
| MNDR | hsa-miR-373-3p | Hilar cholangiocarcinoma | MNDR-E-MI-45383 |
| MNDR | hsa-miR-373-3p | Cholangiocarcinoma | MNDR-E-MI-45384 |
| MNDR | hsa-miR-373-3p | Esophageal cancer | MNDR-E-MI-45385 |
| MNDR | hsa-miR-373-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-45386 |
| MNDR | hsa-miR-373-3p | Testicular germ cell cancer | MNDR-E-MI-45387 |
| MNDR | hsa-miR-373-3p | Hepatocellular carcinoma | MNDR-E-MI-45388 |
| MNDR | hsa-miR-373-3p | Familiar ovarian carcinoma | MNDR-E-MI-45389 |
| MNDR | hsa-miR-373-3p | Retinoblastoma | MNDR-E-MI-45390 |
| MNDR | hsa-miR-373-3p | Burkitt lymphoma | MNDR-E-MI-45391 |
| MNDR | hsa-miR-373-3p | Tonsil cancer | MNDR-E-MI-45392 |
| MNDR | hsa-miR-373-3p | Colorectal cancer | MNDR-E-MI-45393 |
| MNDR | hsa-miR-373-3p | Nasopharynx carcinoma | MNDR-E-MI-45394 |
| MNDR | hsa-miR-373-3p | Multiple myeloma | MNDR-E-MI-45395 |
| MNDR | hsa-miR-373-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-45396 |
| MNDR | hsa-miR-373-3p | Ependymoma | MNDR-E-MI-45397 |
| MNDR | hsa-miR-373-3p | Nasopharyngeal cancer | MNDR-E-MI-45398 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BTG1 | Homo sapiens | RR00234974 |
TOP